Optimism Grows in the Fight Against Cancer as Breakthroughs and Funding Increase

USA News Group Commentary

Issued on behalf of Oncolytics Biotech Inc.

VANCOUVER, BC, Sept. 24, 2024 /PRNewswire/ -- USA News Group – Optimism is on the rise in fight against cancer, as researchers are making progress across the field of oncology. Helping to spur on the momentum, philanthropists recently gave a historic $150 million for pancreatic cancer research to City of Hope, while Stanford experts are calling for more massive federal funding increases to cancer research. According to the latest Cancer Progress Report from the American Association for Cancer Research, the USA has seen a 33% reduction in the overall cancer death rate from 1991 to 2021. Working behind the scenes are several biotech and biopharma companies who've recently made significant developments in the field of oncology, including Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), Nurix Therapeutics, Inc. (NASDAQ: NRIX), Incyte Corporation (NASDAQ: INCY), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), and Foghorn Therapeutics Inc. (NASDAQ: FHTX).